Amit Govil
University of Cincinnati
44 Papers
74 Citations
Amit Govil is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 14, co-authored 40 publications. Previous affiliations of Amit Govil include University of Siena & University of Cincinnati Academic Health Center.
Chat about Author
Papers
Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss
Matthew J Everly,J. J. Everly,Lois J. Arend,Paul Brailey,Brian Susskind,Amit Govil,A.H. Rike,Prabir Roy-Chaudhury,G. Mogilishetty,Rita R. Alloway,Amit D. Tevar,E. S. Woodle +11 more
TL;DR: De novo DSAs detected at rejection are associated with reduced allograft survival, but prompt DSA reduction was associated with improved allografted survival, and DSA should be considered a potential new end point for rejection therapy.
213
Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy.
Christopher M. Freeman,E. S. Woodle,Junzi Shi,Alexander Jw,P. L. Leggett,Shimul A. Shah,Flavio Paterno,Madison C. Cuffy,Amit Govil,G. Mogilishetty,Rita R. Alloway,Dennis J. Hanseman,Michael Cardi,Tayyab S. Diwan +13 more
TL;DR: LSG is a safe and effective means for addressing obesity in kidney transplant candidates in the context of a multidisciplinary approach for patients failing to achieve significant weight loss with medical therapy.
87
Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy.
Al-Faraaz Kassam,Ahmad Mirza,Young Kim,Dennis J. Hanseman,E. Steve Woodle,Ralph C. Quillin,Bobby L. Johnson,Amit Govil,Michael Cardi,Daniel P. Schauer,Eric P. Smith,Tayyab S. Diwan +11 more
TL;DR: Laparoscopic sleeve gastrectomy safely improves transplant candidacy while providing significant, sustainable effects on weight loss, reducing medical comorbidities, and possibly improving renal function in stage 3 patients.
71
Proteasome Inhibition Reduces Donor-Specific Antibody Levels
Matthew J Everly,J. J. Everly,B. Susskind,Paul Brailey,Lois J. Arend,Rita R. Alloway,Prabir Roy-Chaudhury,Amit Govil,G. Mogilishetty,A.H. Rike,M. Cardi,G Wadih,Evan A. Brown,Amit D. Tevar,E. S. Woodle +14 more
- 01 Jan 2009
TL;DR: Preliminary results indicate that proteasome inhibition provides an effective means for reducing HLA antibody levels in transplant recipients with long-term suppression with bortezomib.
63
Use of HCV Ab+/NAT− donors in HCV naïve renal transplant recipients to expand the kidney donor pool
Ann Dao,Madison C. Cuffy,Tiffany E. Kaiser,Ashley Loethen,John Cafardi,Keith Luckett,A. H. Rike,Michael Cardi,Rita R. Alloway,Amit Govil,Tayyab S. Diwan,Kenneth E. Sherman,Shimul A. Shah,E. S. Woodle +13 more
TL;DR: Examination of kidney transplant outcomes provides evidence of a low transmission rate of HCV from HCV Ab+/ NAT− kidney donors, thereby arguing for increasing utilization.
24